Collaborative Capital to Accelerate Medical Breakthroughs

LIFESCI VENTURE PARTNERS

In-depth scientific research drives long term conviction and support through company building, private financing and public markets.

Healthcare Statistical Snapshot
$4.5 TRILLION

2022 forecasted US national 
health expediture


 

Source : STATISTA
65 PERCENT

of molecules in R&D pipeline originate
from emerging biopharma companies


 

Source : IQVIA
$180 Billion

in revenue at risk for large pharma
due to upcoming patent cliffs thru 2028


 

Source : PwC
OUR INVESTMENT APPROACH Transformational Business Models We seek out companies which aim to reshape medical care and the healthcare system through novel approaches to molecular medicine, technology or healthcare delivery. Collaborate with Visionary Management Teams We partner with dynamic entrepreneurs and scientists and assist in executing long term business plans. Mid/Late Stage Venture We principally invest in companies which have achieved proof of concept and plan to transition to the public markets within 24 months.
The LifeSci Partner Platform is a leading global healthcare consultancy that
provides a unique support system for our portfolio companies.
Friendly Capital Friendly Capital Flexible capital structure and friendly terms to support our high growth portfolio companies
Rigorous Due Diligence Process Rigorous Due Diligence Process Long term, high conviction investor, built on thorough scientific and financial expertise
Unique Support for our Portfolio Companies Unique Support for our Portfolio Companies Leverage the global LifeSci Partners network to drive value creation and accelerate business plans
TEAM
Paul Yook Partner & CIO
Ryan Cinalli, PhD Chief Scientific Officer
Ira Kalfus, MD Chief Medical Officer
Julie Mauser Director, Business Development
Brittany Amendola, CPA Controller
Jeff Seo Managing Director, Head of APAC for LifeSci Partners
LIFESCI PARTNERS PLATFORM LifeSci Partners is a global healthcare advisory boutique with 200 experienced investment and science professionals
LS Associates On Demand C-Level Leaders
LifeSci Advisors Investor Relations Services
LifeSci Communications Public Relations and Communications
LifeSci Search Global Executive Recruiting
LifeSci Capital Investment Banking
LifeSci Partnering and Analytics Strategic Partnerships & Market Analytics
PORTFOLIO COMPANIES
CANDID THERAPEUTICS
CANDID THERAPEUTICS
AVERTO MEDICAL
AVERTO MEDICAL
PROFOUND BIO
PROFOUND BIO
VYNE THERAPEUTICS
VYNE THERAPEUTICS
MOMA THERAPEUTICS
MOMA THERAPEUTICS
CLADE THERAPEUTICS
CLADE THERAPEUTICS
LARONDE
LARONDE
ATTRALUS
ATTRALUS
ANTIOS THERAPEUTICS
ANTIOS THERAPEUTICS
PYXIS ONCOLOGY
PYXIS ONCOLOGY
OMEGA THERAPEUTICS
OMEGA THERAPEUTICS
IRIDIA
IRIDIA
BRIGHT MINDS BIOSCIENCES
BRIGHT MINDS BIOSCIENCES
MANA THERAPEUTICS
MANA THERAPEUTICS
CARIBOU BIOSCIENCES
CARIBOU BIOSCIENCES
EGENESIS
EGENESIS
CENTESSA PHARMACEUTICALS
CENTESSA PHARMACEUTICALS
BIONOMICS
BIONOMICS
RAYZEBIO
RAYZEBIO
VIRACTA
VIRACTA
AUGMEDIX
AUGMEDIX
CYBIN
CYBIN
SENTI BIOSCIENCES
SENTI BIOSCIENCES
ALLIEVEX
ALLIEVEX
SCIENCE37

August 2020, Series D-1

Science 37 is a decentralized CRO making the promise of v...

SCIENCE37
ATHIRA
ATHIRA
ERASCA

March 2019, Series A April 2020, Series B

Erasca is a San Diego based biotech company creating a new generation of onc...

ERASCA
CALA HEALTH

May 2019, Series C

Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disea...

CALA HEALTH
BETA BIONICS

January 2019, Series B

Beta Bionics is a medical device company developing the breakthrough iLet system which combines...

BETA BIONICS
AKERO

December 2018, Series B

Akero is a biotechnology company focused on serious metabolic diseases with a lead program, AK...

AKERO
ATTUNE

June 2018, Series B

Attune is a clinical-stage biotechnology company focused on novel small-molecule therapeutics for...

ATTUNE
METACRINE

June 2018, Series C

Metacrine is a San Diego based biotechnology company with exceptional chemistry capabilities and a...

METACRINE
ORASIS

March 2018, Series B

Orasis is a clinical-stage pharmaceutical company developing an innovative eye drop for the treat...

ORASIS
NOVUS

March 2018, At-the-Market
Nasdaq: NVUS

Novus is a specialty pharma company focused on disorders of the near, nose...

NOVUS
COLUMBIA

January 2018, Series D
November 2018, RTO

Columbia Care is one of the largest medical cannabis manufacturers and...

COLUMBIA
ALLAKOS

November 2017, Series B
July 2018, IPO - Nasdaq: ALLK

Allakos is developing AK002, a first-in-class antibody...

ALLAKOS
BIOLINQ
BIOLINQ
ROCKET

March 2017, Series B
January 2018, NASDAQ: RCKT

Rocket Pharma is developing...

ROCKET
ENGAGE

September 2017, Series A

Engage is developing Staccato® Alprazolam, a small, easy-to-use hand-held drug-device com...

ENGAGE
NEWS
LifeSci Venture Partners 152 West 57th Street, 32nd Floor
New York, NY 10019
General Inquiries +1 646.889.1200
to Top